2024 Q4 Form 10-K Financial Statement

#000164033424001515 Filed on October 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q2 2024
Revenue $33.55K
YoY Change -1.08%
Cost Of Revenue $24.63K
YoY Change 29.66%
Gross Profit $8.921K
YoY Change -40.21%
Gross Profit Margin 26.59%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$62.35K
YoY Change 0.87%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$62.46K
YoY Change -4.02%
Net Earnings / Revenue -186.18%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 11.21M shares
Diluted Shares Outstanding 10.79M shares

Balance Sheet

Concept 2024 Q4 2024 Q2 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.836K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $4.836K
YoY Change 126.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $27.83K
YoY Change 119.65%
SHAREHOLDERS EQUITY
Retained Earnings -$128.5K
YoY Change 94.64%
Common Stock $1.121K
YoY Change 9.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$22.99K
YoY Change
Total Liabilities & Shareholders Equity $4.836K
YoY Change 126.19%

Cashflow Statement

Concept 2024 Q4 2024 Q2 2024
OPERATING ACTIVITIES
Net Income -$62.46K
YoY Change -4.02%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$54.74K
YoY Change -15.57%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $50.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $57.44K
YoY Change 683.98%
NET CHANGE
Cash From Operating Activities -$54.74K
Cash From Investing Activities
Cash From Financing Activities $57.44K
Net Change In Cash $2.698K
YoY Change -104.69%
FREE CASH FLOW
Cash From Operating Activities -$54.74K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 jaag Acquiring Interest Rate
AcquiringInterestRate
1 pure
CY2024Q2 us-gaap Liabilities
Liabilities
27825 usd
CY2022Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
200000 shares
CY2022Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
7500000 shares
CY2022Q2 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1 pure
CY2022Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
2508000 shares
CY2022Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
58640 usd
CY2023Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1000000 shares
CY2023Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
50000 usd
CY2024Q2 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
11208000 shares
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001951051
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10208000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11208000 shares
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
333-267995
CY2024 dei Entity Registrant Name
EntityRegistrantName
JAAG ENTERPRISES LTD.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
1716 13 Avenue NW
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Calgary
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
AB
CY2024 dei Entity Address Country
EntityAddressCountry
CA
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
T2N 1L1
CY2024 dei City Area Code
CityAreaCode
403
CY2024 dei Local Phone Number
LocalPhoneNumber
616 - 7221
CY2024 dei Security12g Title
Security12gTitle
Common Stock, $0.0001 par value
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
175400 usd
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11208000 shares
CY2024 dei Auditor Firm
AuditorFirmId
6967
CY2024 dei Auditor Name
AuditorName
CT International LLP
CY2024 dei Auditor Location
AuditorLocation
San Francisco, California
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4836 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2138 usd
CY2024Q2 us-gaap Assets
Assets
4836 usd
CY2023Q2 us-gaap Assets
Assets
2138 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12896 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5181 usd
CY2024Q2 jaag Due To Related Parties Currents
DueToRelatedPartiesCurrents
14929 usd
CY2023Q2 jaag Due To Related Parties Currents
DueToRelatedPartiesCurrents
7487 usd
CY2024Q2 us-gaap Liabilities
Liabilities
27825 usd
CY2023Q2 us-gaap Liabilities
Liabilities
12668 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11208000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1121 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1021 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104343 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54443 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128453 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65994 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-22989 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-10530 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4836 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2138 usd
CY2024 us-gaap Revenues
Revenues
33547 usd
CY2023 us-gaap Revenues
Revenues
33914 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
24626 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
18993 usd
CY2024 us-gaap Gross Profit
GrossProfit
8921 usd
CY2023 us-gaap Gross Profit
GrossProfit
14921 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
71269 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
76732 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-62348 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-61811 usd
CY2024 us-gaap Interest And Other Income
InterestAndOtherIncome
14 usd
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
8 usd
CY2024 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-125 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3273 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-62459 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-65076 usd
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10793831 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10208000 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
54546 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-65076 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-10530 usd
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-62459 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-22989 usd
CY2024 us-gaap Profit Loss
ProfitLoss
62459 usd
CY2023 us-gaap Profit Loss
ProfitLoss
65076 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-641 usd
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7715 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-402 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54744 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-64837 usd
CY2024 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7442 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7327 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
57442 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7327 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2698 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-57510 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2138 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59648 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4836 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2138 usd
CY2024 us-gaap Interest Paid
InterestPaid
0 usd
CY2023 us-gaap Interest Paid
InterestPaid
0 usd
CY2024 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7500000 shares
CY2022Q2 jaag Acquiring Interest Rate
AcquiringInterestRate
1 pure
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.9740 pure
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4836 usd
CY2024Q2 us-gaap Advances To Affiliate
AdvancesToAffiliate
7442 usd
CY2024Q2 jaag Due To Related Partie Advances
DueToRelatedPartieAdvances
14949 usd
CY2024Q2 jaag Accounts Payable Related Parties
AccountsPayableRelatedParties
4560 usd
CY2022Q1 us-gaap Capital
Capital
78 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.165 pure
CY2024Q2 jaag Us Federal Statutory Rate On Us Operations
UsFederalStatutoryRateOnUsOperations
-13116 usd
CY2024 jaag Us Federal Statutory Income Tax Rate On Us Operations
UsFederalStatutoryIncomeTaxRateOnUsOperations
0.210 pure
CY2024Q2 jaag Effect Of Foreign Operations
EffectOfForeignOperations
301 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
-0.005 pure
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12815 usd
CY2024 jaag Valuation Allowance For Deferred Tax Assets Income Tax Rate
ValuationAllowanceForDeferredTaxAssetsIncomeTaxRate
-0.205 pure
CY2024Q2 jaag Total Tax Expenses At Effective Tax Rate
TotalTaxExpensesAtEffectiveTaxRate
0 usd
CY2024 jaag Total Tax Expenses At Effective Income Tax Rate
TotalTaxExpensesAtEffectiveIncomeTaxRate
0 pure
CY2023Q2 jaag Us Federal Statutory Rate On Us Operations
UsFederalStatutoryRateOnUsOperations
-13666 usd
CY2023 jaag Us Federal Statutory Income Tax Rate On Us Operations
UsFederalStatutoryIncomeTaxRateOnUsOperations
0.210 pure
CY2023Q2 jaag Effect Of Foreign Operations
EffectOfForeignOperations
72 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
-0.001 pure
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13594 usd
CY2023 jaag Valuation Allowance For Deferred Tax Assets Income Tax Rate
ValuationAllowanceForDeferredTaxAssetsIncomeTaxRate
-0.210 pure
CY2023Q2 jaag Total Tax Expenses At Effective Tax Rate
TotalTaxExpensesAtEffectiveTaxRate
0 usd
CY2023 jaag Total Tax Expenses At Effective Income Tax Rate
TotalTaxExpensesAtEffectiveIncomeTaxRate
0 pure
CY2024 us-gaap Proceeds From Hedge Financing Activities
ProceedsFromHedgeFinancingActivities
18750 usd

Files In Submission

Name View Source Status
0001640334-24-001515-index-headers.html Edgar Link pending
0001640334-24-001515-index.html Edgar Link pending
0001640334-24-001515.txt Edgar Link pending
0001640334-24-001515-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jaag-20240630.xsd Edgar Link pending
jaag_10k.htm Edgar Link pending
jaag_10kimg1.jpg Edgar Link pending
jaag_10kimg3.jpg Edgar Link pending
jaag_ex311.htm Edgar Link pending
jaag_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
jaag-20240630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
jaag-20240630_def.xml Edgar Link unprocessable
jaag-20240630_lab.xml Edgar Link unprocessable
jaag-20240630_pre.xml Edgar Link unprocessable
jaag_10k_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending